Evaluation of the sensitivities of six triple-negative breast cancer (TNBC) cell lines to 23 different PI3K/AKT/mTOR inhibitors or to a MEK inhibitor (trametinib). Dataset 2 of 2: GR metrics. - Dataset (ID:20365)
Download: Excel (XLSX), Comma-separated (CSV)
Cell line | Drug name | Experimental replicate | Timepoint | Curve type (GR values) | Curve type (relative cell counts) | Experiment name | Number of concentrations | Cell doublings (DMSO control) | GR50 | GRmax | GR_AOC | GEC50 | GRinf | Hill slope (GR values) | R-squared sigmoid fit (GR values) | P-value sigmoid fit (GR values) | R-squared flat fit (GR values) | IC50 | Emax | AUC | EC50 | Einf | Hill slope (relative cell counts) | R-squared sigmoid fit (relative cell counts) | P-value sigmoid fit (relative cell counts) | R-squared flat fit (relative cell counts) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HCC70 | Dactolisib | 2 | 72 | sigmoid | sigmoid | HCC70 dactolisib 0 2 72 | 8 | 1.677 | 0.312 | 0.238 | 0.341 | 0.195 | 0.103 | 0.493 | 0.954 | 9.66e-05 | NA | 2.24 | 0.447 | 0.738 | 0.0858 | 0.419 | 0.56 | 0.954 | 9.8e-05 | NA |
HCC38 | WYE-125132 | 2 | 72 | sigmoid | sigmoid | HCC38 WYE-132 0 2 72 | 8 | 2.143 | 0.0568 | 0.149 | 0.473 | 0.0413 | 0.124 | 0.896 | 0.998 | 9.66e-09 | NA | 0.078 | 0.305 | 0.587 | 0.0297 | 0.285 | 0.875 | 0.997 | 1.58e-08 | NA |
HCC38 | WYE-125132 | 3 | 72 | sigmoid | sigmoid | HCC38 WYE-132 0 3 72 | 8 | 1.449 | 0.0494 | -0.0216 | 0.518 | 0.0504 | -0.0117 | 1.18 | 0.998 | 9.69e-09 | NA | 0.128 | 0.355 | 0.662 | 0.0441 | 0.361 | 1.2 | 0.998 | 9.53e-09 | NA |
HCC38 | Omipalisib | 2 | 72 | sigmoid | sigmoid | HCC38 omipalisib 0 2 72 | 8 | 2.124 | 0.0404 | -0.47 | 0.634 | 0.45 | -1.0 | 0.456 | 0.979 | 9.71e-06 | NA | 0.0507 | 0.0595 | 0.494 | 0.0507 | 0.0 | 0.556 | 0.96 | 6.44e-05 | NA |
BT-20 | Sirolimus | 2 | 72 | flat | flat | BT20 rapamycin 0 2 72 | 8 | 1.952 | Inf | 0.421 | 0.579 | 0.0 | 0.421 | 0.01 | NA | NA | 0.421 | Inf | 0.513 | 0.513 | 0.0 | 0.513 | 0.01 | NA | NA | 0.513 |
BT-20 | Sirolimus | 3 | 72 | flat | flat | BT20 rapamycin 0 3 72 | 8 | 2.661 | Inf | 0.54 | 0.46 | 0.0 | 0.54 | 0.01 | NA | NA | 0.54 | Inf | 0.499 | 0.499 | 0.0 | 0.499 | 0.01 | NA | NA | 0.499 |
BT-20 | Everolimus | 2 | 72 | flat | flat | BT20 everolimus 0 2 72 | 8 | 1.785 | Inf | 0.426 | 0.574 | 0.0 | 0.426 | 0.01 | NA | NA | 0.426 | Inf | 0.547 | 0.547 | 0.0 | 0.547 | 0.01 | NA | NA | 0.547 |